Globalisation on pause? How scaleups can navigate today's uncertainty9:30 am - 10:30 am
The medtech company TidalSense, formerly Cambridge Respiratory Innovations (CRI), creates ground-breaking respiratory technologies.
TidalSense first received funding from BGF and Downing Ventures in December 2020, to fast-track research and development of its award-winning N-Tidal device.
The N-Tidal device is a first-in-kind, connected, handheld capnometer incorporating unique patented sensor technology, that can accurately measure carbon dioxide levels in exhaled breath during normal breathing. It helps medical professionals diagnose and monitor respiratory conditions.
Business funding insights
A post-exit perspective—with Leigh Howarth, CEO of STATS Group
In August, we announced the successful exit of our investment in STATS Group, an Aberdeen-based pipeline technology specialist for the global energy…
How BGF is helping companies to expand internationally: Elvie & OSL
BGF can support your business to expand overseas, just as we did with fast-growing femtech company Elvie and counter-drone tech business OSL. Read the case studies to learn more.